Delivery Order SPE2DB20D1100-SPE2DB25FC4W0

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of TIVICAY 50 MG TABLET 30S. The contract has a ceiling value of $2,294.48 and an ultimate completion date of January 3, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $5,647.31 and a period of performance through October 15, 2024. The contract is a firm fixed-price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which serves as the primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, with a firm fixed price of $11,100.30 and a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a $27,890.73 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 MG TABLET 30S. The contract has a period of performance through July 31, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded this delivery order as part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,135.99, is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. This contract does not have a set-aside designation, indicating it was an open competition. The contract is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a prescription medication, with a ceiling value of $7,359.00 and a performance period ending on May 13, 2025. The contract is a firm fixed-price, non-set-aside vehicle, meaning it was awarded through open competition. AmerisourceBergen Drug Corp also holds...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of TIVICAY 50 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $4,992.28 and a period of performance through October 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TIVICAY 50MG TABS 30S at a firm fixed price of $54,258.82. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific socioeconomic program. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,821.38 award is for the supply of TIVICAY 50 MG TABLET 30S, a prescription medication. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $20,990.66 and a performance period ending on May 19, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC4W0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TIVICAY 50 MG TABLET 30S. The award has a ceiling value of $44,232.67 and is a firm fixed price contract. The period of performance extends through May 23, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order is issued under that broader IDC vehicle, which does not have a set-aside designation, indicating open competition.

Generated 8/21/25, 10:05 AM